Navidea Biopharmaceuticals Reaches Interim Analysis Point of Phase 3 Head and Neck Cancer Study of Lymphoseek® Jan 3, 2013
Navidea Biopharmaceuticals Announces Presentation at the 2013 Biotech Showcase™ Conference Jan 2, 2013
Navidea Biopharmaceuticals Submits Lymphoseek Marketing Authorization Application to European Medicines Agency Dec 18, 2012
Navidea Biopharmaceuticals Announces the Presentation of Lymphoseek® Data at Upcoming Scientific Meetings Nov 26, 2012
Navidea Biopharmaceuticals Announces PDUFA Goal Date for Lymphoseek® New Drug Application Resubmission Nov 13, 2012
Navidea Awarded SBIR Grant from the NIH for Development of Radio-Immuno-Guided Surgery (RIGS) Agent Aimed at Detecting Metastatic Cancer Sep 20, 2012
Navidea Biopharmaceuticals Announces the Presentation of Lymphoseek® Phase 3 Meta-Analysis Data at the 32nd Congress of the European Society of Surgical Oncology Sep 20, 2012
